ziconotide and Carcinoma--Transitional-Cell

Intrathecal ziconotide is used for the treatment of chronic pain and is delivered by an implanted drug delivery device. Anesthesiologists should be familiar with the perioperative management of the pump as well as the potential adverse events related to continued ziconotide infusion during general anesthesia. A case is presented demonstrating the perioperative management of an intrathecal drug delivery device infusing ziconotide in a patient presenting for radical cystectomy with pelvic lymphadenectomy and ileal conduit diversion.

Topics: Aged; Analgesics, Non-Narcotic; Anesthesia, General; Carcinoma, Transitional Cell; Chronic Pain; Cystectomy; Deprescriptions; Humans; Infusion Pumps, Implantable; Infusions, Spinal; Intraoperative Complications; Low Back Pain; Lymph Node Excision; Male; omega-Conotoxins; Pelvis; Perioperative Care; Urinary Bladder Neoplasms; Urinary Diversion; Vasoplegia